Notice Concerning the Establishment of OrphanPacific, Inc.
It is announced that OrphanPacific Inc., a manufacturing and sales company of ethical drugs with a focus on orphan drugs (drugs for treating rare diseases), has been established on May 1, 2012, with funding from CMIC HOLDINGS Co., Ltd. (Representative Director: Kazuo Nakamura) and MEDIPAL HOLDINGS CORPORATION (Representative Director: Shuichi Watanabe).
|1. Company Name:||OrphanPacific, Inc.|
|2. Established:||May 1, 2012|
|3. Location:||Kongo Building 3F, 7-10-4 Nishigotanda, Shinagawa-ku, Tokyo|
|5. Capital:||100 million yen|
|6. Shareholders:||CMIC HOLDINGS Co., Ltd. 51%
MEDIPAL HOLDINGS CORPORATION 49%
|7. Main Line of Business:||Manufacturing and sales of pharmaceutical products|